384
Participants
Start Date
November 6, 2003
Primary Completion Date
December 22, 2004
Study Completion Date
February 24, 2020
National Cancer Institute (NCI), 9000 Rockville Pike, Bethesda
National Cancer Institute (NCI)
NIH